BriaCell Therapeutics Corp.

BCTXZ

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001610820

SEC filings (opens in a new tab)

No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $61.7K in total; no superinvestor holds it.

Other share classesBCTX BCTXL

Superinvestors holding BCTXZ, Q2 2026

See all superinvestors

No superinvestor reported holding BCTXZ in Q2 2026.